| Year |
Citation |
Score |
| 2016 |
Alexandrov V, Brunner D, Menalled LB, Kudwa A, Watson-Johnson J, Mazzella M, Russell I, Ruiz MC, Torello J, Sabath E, Sanchez A, Gomez M, Filipov I, Cox K, Kwan M, et al. Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice. Nature Biotechnology. PMID 27376585 DOI: 10.1038/Nbt.3587 |
0.355 |
|
| 2016 |
Onajole OK, Vallerini GP, Eaton JB, Lukas RJ, Brunner D, Caldarone BJ, Kozikowski AP. Synthesis and Behavioral Studies of Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part III. Acs Chemical Neuroscience. PMID 27035276 DOI: 10.1021/Acschemneuro.6B00050 |
0.308 |
|
| 2016 |
Wheeler VC, Kovalenko M, Giordano J, Andrew M, Menalled L, Alexandrov V, Thiede C, Weidner J, Teichmann K, Tottey W, Cumming SA, Correia K, Barker D, Lager B, Flynn G, ... ... Brunner D, et al. B1 HTT CAG knock-in mice with pure and interrupted repeat tracts provide insight into the role of somatic expansion in HD pathogenesis Journal of Neurology, Neurosurgery & Psychiatry. 87: A9.2-A9. DOI: 10.1136/Jnnp-2016-314597.32 |
0.393 |
|
| 2014 |
Yu LF, Brek Eaton J, Zhang HK, Sabath E, Hanania T, Li GN, van Breemen RB, Whiteaker P, Liu Q, Wu J, Chang YC, Lukas RJ, Brunner D, Kozikowski AP. The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profile. Pharmacology Research & Perspectives. 2: e00026. PMID 25505580 DOI: 10.1002/Prp2.26 |
0.318 |
|
| 2014 |
Milekic MH, Xin Y, O'Donnell A, Kumar KK, Bradley-Moore M, Malaspina D, Moore H, Brunner D, Ge Y, Edwards J, Paul S, Haghighi FG, Gingrich JA. Age-related sperm DNA methylation changes are transmitted to offspring and associated with abnormal behavior and dysregulated gene expression. Molecular Psychiatry. PMID 25092244 DOI: 10.1038/Mp.2014.84 |
0.45 |
|
| 2014 |
Farrar AM, Murphy CA, Paterson NE, Oakeshott S, He D, Alosio W, McConnell K, Menalled LB, Ramboz S, Park LC, Howland D, Brunner D. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease. Journal of Huntington's Disease. 3: 145-58. PMID 25062858 DOI: 10.3233/Jhd-130061 |
0.376 |
|
| 2014 |
Menalled LB, Kudwa AE, Oakeshott S, Farrar A, Paterson N, Filippov I, Miller S, Kwan M, Olsen M, Beltran J, Torello J, Fitzpatrick J, Mushlin R, Cox K, McConnell K, ... ... Brunner D, et al. Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6/2 and zQ175 mouse models of Huntington's disease. Plos One. 9: e99520. PMID 24955833 DOI: 10.1371/Journal.Pone.0099520 |
0.348 |
|
| 2013 |
Oakeshott S, Farrar A, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, Ramboz S, Howland D, Brunner D. Deficits in a Simple Visual Go/No-go Discrimination Task in Two Mouse Models of Huntington's Disease. Plos Currents. 5. PMID 24270512 DOI: 10.1371/Currents.Hd.Fe74C94Bdd446A0470F6F905A30B5Dd1 |
0.372 |
|
| 2013 |
Kudwa AE, Menalled LB, Oakeshott S, Murphy C, Mushlin R, Fitzpatrick J, Miller SF, McConnell K, Port R, Torello J, Howland D, Ramboz S, Brunner D. Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington's Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits. Plos Currents. 5. PMID 24042107 DOI: 10.1371/Currents.Hd.0Ab4F3645Aff523C56Ecc8Ccbe41A198 |
0.379 |
|
| 2013 |
Balci F, Oakeshott S, Shamy JL, El-Khodor BF, Filippov I, Mushlin R, Port R, Connor D, Paintdakhi A, Menalled L, Ramboz S, Howland D, Kwak S, Brunner D. High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington's Disease. Plos Currents. 5. PMID 23863947 DOI: 10.1371/Currents.Hd.124Aa0D16753F88215776Fba102Ceb29 |
0.606 |
|
| 2013 |
Gunosewoyo H, Midzak A, Gaisina IN, Sabath EV, Fedolak A, Hanania T, Brunner D, Papadopoulos V, Kozikowski AP. Characterization of maleimide-based glycogen synthase kinase-3 (GSK-3) inhibitors as stimulators of steroidogenesis. Journal of Medicinal Chemistry. 56: 5115-29. PMID 23725591 DOI: 10.1021/Jm400511S |
0.302 |
|
| 2012 |
Oakeshott S, Port R, Cummins-Sutphen J, Berger J, Watson-Johnson J, Ramboz S, Paterson N, Kwak S, Howland D, Brunner D. A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington's disease. Plos Currents. 4: e4f972cffe82c0. PMID 23925262 DOI: 10.1371/4F972Cffe82C0 |
0.35 |
|
| 2012 |
Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, Connor D, Murphy C, Oakeshott S, Kwan M, Beltran J, ... ... Brunner D, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175. Plos One. 7: e49838. PMID 23284626 DOI: 10.1371/Journal.Pone.0049838 |
0.414 |
|
| 2012 |
Menalled L, El-Khodor BF, Hornberger M, Park L, Howland D, Brunner D. Effect of the rd1 mutation on motor performance in R6/2 and wild type mice. Plos Currents. 4: RRN1303. PMID 22367489 DOI: 10.1371/Currents.Rrn1303 |
0.308 |
|
| 2011 |
Oakeshott S, Port RG, Cummins-Sutphen J, Watson-Johnson J, Ramboz S, Park L, Howland D, Brunner D. HD mouse models reveal clear deficits in learning to perform a simple instrumental response. Plos Currents. 3: RRN1282. PMID 22512000 DOI: 10.1371/Currents.Rrn1282 |
0.352 |
|
| 2011 |
Roberds SL, Filippov I, Alexandrov V, Hanania T, Brunner D. Rapid, computer vision-enabled murine screening system identifies neuropharmacological potential of two new mechanisms. Frontiers in Neuroscience. 5: 103. PMID 21927596 DOI: 10.3389/Fnins.2011.00103 |
0.32 |
|
| 2011 |
Oakeshott S, Balci F, Filippov I, Murphy C, Port R, Connor D, Paintdakhi A, Lesauter J, Menalled L, Ramboz S, Kwak S, Howland D, Silver R, Brunner D. Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington's Disease. Plos Currents. 3: RRN1225. PMID 21479110 DOI: 10.1371/Currents.Rrn1225 |
0.578 |
|
| 2010 |
Balci F, Ludvig EA, Brunner D. Within-session modulation of timed anticipatory responding: when to start responding. Behavioural Processes. 85: 204-6. PMID 20600698 DOI: 10.1016/J.Beproc.2010.06.012 |
0.545 |
|
| 2010 |
Balci F, Ludvig EA, Abner R, Zhuang X, Poon P, Brunner D. Motivational effects on interval timing in dopamine transporter (DAT) knockdown mice. Brain Research. 1325: 89-99. PMID 20167208 DOI: 10.1016/J.Brainres.2010.02.034 |
0.588 |
|
| 2009 |
Balci F, Day M, Rooney A, Brunner D. Disrupted temporal control in the R6/2 mouse model of Huntington's disease. Behavioral Neuroscience. 123: 1353-8. PMID 20001119 DOI: 10.1037/A0017650 |
0.621 |
|
| 2009 |
Nemirovsky SI, Avale ME, Brunner D, Rubinstein M. Reward-seeking and discrimination deficits displayed by hypodopaminergic mice are prevented in mice lacking dopamine D4 receptors. Synapse (New York, N.Y.). 63: 991-7. PMID 19598175 DOI: 10.1002/Syn.20680 |
0.3 |
|
| 2009 |
Balci F, Gallistel CR, Allen BD, Frank KM, Gibson JM, Brunner D. Acquisition of peak responding: what is learned? Behavioural Processes. 80: 67-75. PMID 18950695 DOI: 10.1016/J.Beproc.2008.09.010 |
0.527 |
|
| 2008 |
Balci F, Ludvig EA, Gibson JM, Allen BD, Frank KM, Kapustinski BJ, Fedolak TE, Brunner D. Pharmacological manipulations of interval timing using the peak procedure in male C3H mice. Psychopharmacology. 201: 67-80. PMID 18648777 DOI: 10.1007/S00213-008-1248-Y |
0.534 |
|
| 2008 |
Balci F, Papachristos EB, Gallistel CR, Brunner D, Gibson J, Shumyatsky GP. Interval timing in genetically modified mice: a simple paradigm. Genes, Brain, and Behavior. 7: 373-84. PMID 17696995 DOI: 10.1111/J.1601-183X.2007.00348.X |
0.614 |
|
| 2004 |
El-Khodor BF, Dimmler MH, Amara DA, Hofer M, Hen R, Brunner D. Juvenile 5HT(1B) receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT(1A) receptor activation. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 22: 405-13. PMID 15380839 DOI: 10.1016/J.Ijdevneu.2004.06.001 |
0.471 |
|
| 2004 |
Compan V, Zhou M, Grailhe R, Gazzara RA, Martin R, Gingrich J, Dumuis A, Brunner D, Bockaert J, Hen R. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 412-9. PMID 14724239 DOI: 10.1523/Jneurosci.2806-03.2004 |
0.507 |
|
| 2003 |
Weller A, Leguisamo AC, Towns L, Ramboz S, Bagiella E, Hofer M, Hen R, Brunner D. Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. Developmental Psychobiology. 42: 194-205. PMID 12555283 DOI: 10.1002/Dev.10079 |
0.625 |
|
| 2002 |
Kacelnik A, Brunner D. Timing and foraging: Gibbon's scalar expectancy theory and optimal patch exploitation Learning and Motivation. 33: 177-195. DOI: 10.1006/Lmot.2001.1110 |
0.319 |
|
| 2000 |
Gross C, Santarelli L, Brunner D, Zhuang X, Hen R. Altered fear circuits in 5-HT(1A) receptor KO mice. Biological Psychiatry. 48: 1157-63. PMID 11137057 DOI: 10.1016/S0006-3223(00)01041-6 |
0.389 |
|
| 1999 |
Brunner D, Buhot MC, Hen R, Hofer M. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behavioral Neuroscience. 113: 587-601. PMID 10443785 DOI: 10.1037//0735-7044.113.3.587 |
0.477 |
|
| 1999 |
Grailhe R, Waeber C, Dulawa SC, Hornung JP, Zhuang X, Brunner D, Geyer MA, Hen R. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A) receptor. Neuron. 22: 581-91. PMID 10197537 DOI: 10.1016/S0896-6273(00)80712-6 |
0.386 |
|
| 1998 |
Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proceedings of the National Academy of Sciences of the United States of America. 95: 14476-81. PMID 9826725 DOI: 10.1073/Pnas.95.24.14476 |
0.381 |
|
| Show low-probability matches. |